Wells Fargo Starts Ascendis Pharma (ASND) at Overweight
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $248.50 +0.92%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo analyst Chris M. Carey initiates coverage on Ascendis Pharma (NASDAQ: ASND) with a Overweight rating and a price target of $176.00.
For an analyst ratings summary and ratings history on Ascendis Pharma click here. For more ratings news on Ascendis Pharma click here.
Shares of Ascendis Pharma closed at $136.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ascendis Pharma (ASND) PT Raised to $341 at TD Cowen
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
